"Atlanta Diabetes Associates
Welcome,         Profile    Billing    Logout  
 9 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bode, Bruce
NCT04628481: A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Recruiting
3
327
Europe, US, RoW
Ladarixin, allosteric inhibitor of CXCL8 (IL-8), CXCR1 and CXCR2 receptors, Placebo
Dompé Farmaceutici S.p.A
New-onset type1 Diabetes
06/23
06/24
SURPASS-CVOT, NCT04255433 / 2019-002735-28: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Checkmark Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes.
Checkmark [VIRTUAL] The Dual GIP/GLP-1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Protein Biomarkers in Patients With Type 2 Diabetes
Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Dulaglutide, LY2189265
Eli Lilly and Company
Type 2 Diabetes Mellitus
10/24
10/24
NCT04823312: Evaluation of Medtronic DUO Extended Set

Recruiting
N/A
20
US
Experimental prospective single arm evaluating the Medtronic Duo Extended Set, Medtronic DUO Extended Set with 670G Pump Therapy
Atlanta Diabetes Associates, Medtronic
Diabetes Mellitus, Type 1
10/21
11/21
NCT05238142: In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

Recruiting
N/A
300
US
MiniMed™ 780G Insulin Pump system
Medtronic Diabetes
Type 2 Diabetes Treated With Insulin
01/23
05/23
NCT05409131: Omnipod 5 System Compared to Pump Therapy

Recruiting
N/A
200
Europe, US
Omnipod 5 System
Insulet Corporation
Type 1 Diabetes
03/23
06/23
NCT05224258: Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Recruiting
N/A
250
Europe, Canada, US
MiniMed 780G System
Medtronic Diabetes
Type 1 Diabetes
05/23
06/23
NCT05325294: Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Recruiting
N/A
250
US
MiniMed 780G System
Medtronic Diabetes, Eli Lilly and Company
Type 1 Diabetes
05/23
05/23
NCT04809285: Use of the Guardian™ Connect System With Smart Connected Devices

Recruiting
N/A
500
US
Guardian™ Connect system, InPen™ Basal smart cap, smart insulin pens, and InPen™ Diabetes Management app
Medtronic Diabetes
Type 1 Diabetes Mellitus
08/23
08/23
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study

Recruiting
N/A
925
US
Blood glucose meter, Eversense CGM System
Senseonics, Inc.
Diabetes
03/26
03/26

Download Options